Xeltis' Axess Restorative Hemodialysis Access Graft Evaluated in Early Data From FIH Trial
April 27, 2022—Xeltis announced preliminary results from a clinical trial of the company’s Axess restorative hemodialysis access graft. Ax
Source: evtoday.com